Immunology and Microbiology
Keratinocyte
92%
Secukinumab
61%
Tumor Necrosis Factor
44%
Interleukin 17
38%
Signal Transduction
38%
Dermatitis
35%
Biological Product
30%
CCL20
25%
CHI3L1
23%
Mouse
23%
Decision Trees
23%
Mitogen
20%
CCL5
15%
Gene Expression
15%
STAT2
15%
CXCL11
15%
Interleukin 19
15%
Interleukin 20
15%
Tumor Necrosis Factor Alpha
15%
Classification Algorithm
15%
Single Nucleotide Polymorphism
15%
Interleukin 17
15%
Drug Targeting
12%
Dynamics
10%
Immunocompetent Cell
9%
Cytokine
9%
Knockout Mouse
8%
Normal Human
7%
Wild Type Mouse
6%
Proinflammatory Cytokine
6%
Gene Expression Profiling
5%
Transcriptome
5%
Human Leukocyte Antigen
5%
Aminopeptidase
5%
Promoter Region
5%
Transcriptomics
5%
Peripheral Blood Mononuclear Cell
5%
down Regulation
5%
Upregulation
5%
Transcription Factors
5%
Thymus and Activation Regulated Chemokine
5%
Monoclonal Antibody
5%
Transcription Factor AP 1
5%
Immunity
5%
Endoplasmic reticulum
5%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Secukinumab
36%
Interleukin 17
35%
Biological Product
33%
Cytokine
23%
Cohort Study
20%
Tumor Necrosis Factor
20%
Psoriasis Vulgaris
20%
Adverse Event
17%
I Kappa B
15%
Pustulosis palmoplantaris
15%
Biological Marker
15%
Antipsoriasis Agent
15%
Systemic Treatment
15%
Suppurative Hidradenitis
15%
Ustekinumab
8%
Nuclear Factor
7%
Adalimumab
6%
Tree
6%
Dermatitis
6%
Ixekizumab
5%
Thymus and Activation Regulated Chemokine
5%
Transcription Factor AP 1
5%
Transcription Factors
5%
Organic Cation Transporter 1
5%
Skin Disease
5%
Comorbidity
5%
Medicine and Dentistry
Psoriasis
61%
Biological Therapy
33%
Adalimumab
22%
Secukinumab
22%
Cohort Analysis
20%
Biological Product
19%
Disease
18%
Pustulosis Palmaris Et Plantaris
15%
Hidradenitis Suppurativa
15%
Low Level Laser Therapy
15%
Acneiform Eruption
15%
Biosimilar
15%
Climatotherapy
15%
Malignant Neoplasm
15%
Laser Hair Removal
15%
Immunosuppressive Treatment
15%
Ustekinumab
8%
Logistic Regression Analysis
7%
Scar Formation
7%
Dermatitis
6%
Clinician
5%
Recurrent Disease
5%
Tumor Necrosis Factor
5%
Comorbidity
5%
Diseases
5%
Dermatological Disease
5%
